BRIEF-Theravance Biopharma highlights positive results from phase 3 fulfil study of closed triple announced by Glaxosmithkline, Innoviva

* Highlights positive top-line results from pivotal phase 3 fulfil study of closed triple announced by Glaxosmithkline, Innoviva
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.